UNSPSC 51101652: Difetarsone

This classification denotes an antiprotozoal agent with the molecular formula C14H18As2N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4G9J3Q65W, chemically known as n,n-ethylenediarsanilic acid but generally known as difetarsone, which bears US NIH Compound Identifier 68199. European Medicines Agency schedules Difetarsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07124MIG.

UNSPSC 51101652 Difetarsone is a Commodity code that in recent state and local procurement activity covers the supply of pharmaceutical products—including antibiotics, opioid-reversal agents, and related medical consumables—through piggyback and direct-purchase contracts. State and local governments acquire these products through public health departments, county health authorities, and emergency-management agencies to support disease prevention, community health initiatives, and emergency response. Issuing bodies include state health departments and county governments with direct procurement authority over pharmaceutical inventory.

Recent activity shows Illinois Department of Public Health awarding a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over three years for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under Invitation for Bid (IFB) 26482DPHPREPDB53392. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking annual supply of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly delivery to the Seminole County Community Health Building in Sanford, with a two-year contract term and one-year renewal option. Recent procurement activity is concentrated in Florida and Illinois, with purchasing driven by public health agencies and county health departments acquiring pharmaceuticals through cooperative purchasing vehicles and competitive sealed-bid processes.